Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
19%
OVERLAP
BY WEIGHT
17
# OF OVERLAPPING
HOLDINGS
CANC
52
HOLDINGS
33%
ALSO IN SBIO
SBIO
90
HOLDINGS
21%
ALSO IN CANC
SECTOR DRIFT (CANC minus SBIO)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
NUVALENT, INC. CLASS A | 3.4% | 3.1% | 3.1% |
|
ARCELLX, INC. | 3.5% | 2.1% | 2.1% |
|
CELCUITY INC. | 2.6% | 1.8% | 1.8% |
 |
MERUS N.V. | 1.5% | 3.2% | 1.5% |
|
CG ONCOLOGY, INC. | 1.3% | 1.5% | 1.3% |
CANC Overweight Relative to SBIO
|
REVOLUTION MEDICINES, INC. | 7.1% |
|
ELI LILLY & CO | 5.9% |
|
BRIDGEBIO PHARMA, INC. | 4.3% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 4.3% |
 |
ASTRAZENECA PLC | 3.8% |
 |
GENMAB A/S SPONSORED ADR | 3.7% |
|
COGENT BIOSCIENCES INC | 3.7% |
|
NOVARTIS AG | 3.6% |
|
EXELIXIS INC | 2.8% |
|
ABBVIE INC | 2.6% |
CANC Underweight Relative to SBIO
|
AVIDITY BIOSCIENCES INC | -4.7% |
|
CYTOKINETICS INC | -3.5% |
|
AXSOME THERAPEUTICS, INC. | -3.4% |
|
RHYTHM PHARMACEUTICALS, INC. | -3.1% |
|
VAXCYTE, INC. | -2.7% |
|
PTC THERAPEUTICS INC | -2.7% |
|
KRYSTAL BIOTECH, INC. | -2.7% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -2.5% |
|
PROTAGONIST THERAPEUTICS, INC. | -2.3% |
 |
ALKERMES PLC | -2.1% |